Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Stacy D D'Andre"'
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly di
Externí odkaz:
https://doaj.org/article/7b4a8b2c7d344b0e9344d197a7338b0a
Autor:
Joyce F. Liu, Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher, David Cella, William P. Tew, Noelle G. Cloven, Carolyn Y. Muller, David P. Bender, Richard G. Moore, David P. Michelin, Steven E. Waggoner, Melissa A. Geller, Keiichi Fujiwara, Stacy D. D'Andre, Michael Carney, Angeles Alvarez Secord, Katherine M. Moxley, Michael A. Bookman
Publikováno v:
J Clin Oncol
PURPOSE Platinum-based chemotherapy is the standard of care for platinum-sensitive ovarian cancer, but complications from repeated platinum therapy occur. We assessed the activity of two all-oral nonplatinum alternatives, olaparib or olaparib/cediran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e9341979352c4a3d4d53e5247e5a4f
https://pubmed.ncbi.nlm.nih.gov/35290101
https://pubmed.ncbi.nlm.nih.gov/35290101
Autor:
Stacy D. D’Andre, Brent A. Bauer, Margaret B. Hofmann, Jenna L. Burckhard, Heather N. Montane, Charles L. Loprinzi
Publikováno v:
Supportive Care in Cancer. 31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80a07dba7fea412f6fd14968c9abf3ad
https://doi.org/10.1007/s00520-022-07504-6
https://doi.org/10.1007/s00520-022-07504-6
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)
Following publication of the original article [1], the authors reported an error in the spelling of one of the author names. In this Correction the incorrect and correct author names are indicated and the author name has been updated in the original
Externí odkaz:
https://doaj.org/article/523386e861dd4740aa938b4e7fa9768c
Autor:
Paulina S Marell, Robert A Vierkant, Janet E Olson, Joerg Herrmann, Nicole Larson, Nathan K LeBrasseur, Stacy D D’Andre, Andrea L Cheville, Toure Barksdale, Charles L Loprinzi, Fergus Couch, Kathryn J Ruddy
Publikováno v:
The oncologist. 27(10)
Physical activity (PA) is associated with improvement in breast cancer treatment-related symptoms and survival, yet most breast cancer survivors do not meet national PA guidelines. This study aimed to identify characteristics of participants that wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1109a5ca7099bd3a01f3059ec9cce6e9
https://pubmed.ncbi.nlm.nih.gov/35946834
https://pubmed.ncbi.nlm.nih.gov/35946834
Autor:
Paulina S. Marell, Janet E. Olson, Joerg Herrmann, Nicole L. Larson, Nathan K. LeBrasseur, Stacy D. D'Andre, Andrea L. Cheville, Toure Barksdale, Charles L. Loprinzi, Fergus J. Couch, Kathryn J. Ruddy
Publikováno v:
Cancer Research. 82:5868-5868
BACKGROUND: The American Cancer Society recommends at least 150 minutes of moderate and/or strenuous exercise and muscle-strengthening activities each week for adults. Exercise has been associated with decreased breast cancer mortality and adverse sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d65c016923cdda95efed95fa3028bab
https://doi.org/10.1158/1538-7445.am2022-5868
https://doi.org/10.1158/1538-7445.am2022-5868
Autor:
Stacy D. D'Andre, Brent D. Bauer, Maggie D. Hofmann, Jenna D. Burckhard, Heather D. Montane, Charles L. Loprinzi
Publikováno v:
Journal of Clinical Oncology. 40:12058-12058
12058 Background: It is well established that many patients with cancer are taking dietary supplements (DS) and alternative medicines and often do not disclose such to their care teams. There is potential for harm in several ways: 1) interactions wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a4f027ff1b32ba121bdc19d6722b398
https://doi.org/10.1200/jco.2022.40.16_suppl.12058
https://doi.org/10.1200/jco.2022.40.16_suppl.12058
Autor:
Laura Catherine Farrington, Alissa S. Marr, Stacy D. D'Andre, Scott M. Schuetze, Margaret von Mehren, Carmen Calfa, Michael Rothe, Michael B. Livingston, Pam K. Mangat, Funda Meric-Bernstam, Richard L. Schilsky, Ramya Thota, Liz Garrett-Mayer, Kristopher Wentzel
Publikováno v:
Journal of Clinical Oncology. 39:11565-11565
11565 Background: TAPUR is a phase II basket study evaluating anti-tumor activity of commercially available targeted agents in pts with advanced cancers with genomic alterations. Results in a cohort of STS pts with CDK4 amplification treated with P a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e64bf5c3dfce438d4d503b70242c986
https://doi.org/10.1200/jco.2021.39.15_suppl.11565
https://doi.org/10.1200/jco.2021.39.15_suppl.11565
Autor:
Liz Garrett-Mayer, Richard L. Schilsky, Jessica Bauman, Evan P. Pisick, Ani Sarkis Balmanoukian, Stacy D. D'Andre, Min S. Park, Daniel R. Carrizosa, Ramya Thota, Francis P. Worden, Rom S. Leidner, Steven Francis Powell, Siqing Fu, Michael Rothe, Lisle Nabell, Pam K. Mangat, Carmen Calfa
Publikováno v:
Journal of Clinical Oncology. 39:6043-6043
6043 Background: TAPUR is a phase II basket study evaluating anti-tumor activity of commercially available targeted agents in pts with advanced cancers with genomic alterations. Results in a cohort of HNC pts with CDKN2A loss or mutation treated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::020fd58e6d38b4bae3d599c623d0300f
https://doi.org/10.1200/jco.2021.39.15_suppl.6043
https://doi.org/10.1200/jco.2021.39.15_suppl.6043
Publikováno v:
Journal of Clinical Oncology. 38:e24111-e24111
e24111 Background: Despite the fact that cannabis is still illegal in some states, two-thirds of all patients with cancer may have used cannabis at some point in their life to alleviate anorexia, nausea, chronic pain, and/or insomnia. Cannabis remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1475c509510bca21fa38d54b82ea9dfe
https://doi.org/10.1200/jco.2020.38.15_suppl.e24111
https://doi.org/10.1200/jco.2020.38.15_suppl.e24111